KyungDong Pharm Co., Ltd. launches the 'Olodipine HCT Tablet' series, a triple drug combination drug for high blood pressure, on April 1, 2019.
'Olodipine HCT Tablet' is a three-drug combination medicine that combines three ingredients, 'amlodipine', 'olmesartan medoxomil', and 'hydrochlorothiazide'.
Combination therapy of amlodipine and olmesartan medoxomil can be administered for essential hypertension whose blood pressure is not properly controlled.
It is taken once a day regardless of meals, and the released doses are 5/20/12.5mg, 5/40/12.5mg, and 10/40/12.5mg.
- Product Information -
1. Composition and Strength (in 1 tablet - active ingredient)
|
ingredient |
Content (5/20/12.5) |
Content (5/40/12.5) |
Content (10/40/12.5) |
|
amlodipine besylate |
5mg |
5mg |
10mg |
|
Olmesartan medoxomil |
20mg |
40mg |
40mg |
|
Hydrochlorothiazide |
12.5mg |
12.5mg |
12.5mg |
2. Effectiveness
Essential hypertension in which blood pressure is not adequately controlled with combination therapy of amlodipine and olmesartan medoxomil.
3. Dosage and dosage
Take this medication 1 tablet once a day with water, regardless of meal. If possible, it is recommended to take it at the same time every day (e.g. in the morning).
The maximum dosage of this drug is 10/40/12.5 mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide.
* Please refer to the product manual for other details, such as precautions for use.